Condition
Calcium Phosphate Kidney Stones
Total Trials
4
Recruiting
1
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 15/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (1)
Early P 1 (1)
P 2 (1)
P 4 (1)
Trial Status
Enrolling By Invitation1
Not Yet Recruiting1
Completed1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07465367Not ApplicableNot Yet RecruitingPrimary
Methionine for CaPhos Stone
NCT06987084Early Phase 1Enrolling By Invitation
Bryophyllum Pinnatum Tea as a Novel Treatment for Recurrent Kidney Stone Formers
NCT06003348Phase 4RecruitingPrimary
Hydroxycitrate: A Novel Therapy for Calcium Phosphate Urinary Stones
NCT01754779Phase 2CompletedPrimary
Treatment for Calcium Phosphate Kidney Stone Disease
Showing all 4 trials